INSULIN ASPART — all Canadian products
13 DINs
10 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INSULIN ASPART, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02460408 | FIASP | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02460416 | FIASP | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02520982 | KIRSTY | BIOCON BIOLOGICS CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Approved | |
| 02520974 | KIRSTY | BIOCON BIOLOGICS CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02265435 | NOVOMIX 30 | NOVO NORDISK CANADA INC | Suspension | Subcutaneous | INSULIN ASPART 30 UNIT; INSULIN ASPART PROTAMINE 70 UNIT | Marketed | |
| 02244353 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02245397 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02506564 | TRURAPI | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02506572 | TRURAPI | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02529254 | TRURAPI | SANOFI-AVENTIS CANADA INC | Solution | Intravenous; Subcutaneous | INSULIN ASPART 100 UNIT | Marketed | |
| 02460424 | FIASP | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Dormant | |
| 02265443 | NOVOMIX 30 (FLEXPEN) | NOVO NORDISK CANADA INC | Suspension | Subcutaneous | INSULIN ASPART 30 %; INSULIN ASPART PROTAMINE 70 % | Cancelled Pre Market | |
| 02377209 | NOVORAPID | NOVO NORDISK CANADA INC | Solution | Subcutaneous | INSULIN ASPART 100 UNIT | Cancelled Post Market |
Browse other molecules: